RespTalks - Underlying inflammation in patients with severe/ uncontrolled CRSwNP: from targeting type 2 pathophysiology to shared clinical decision-making
Join us for this enlightening discussion!
We are delighted to invite you to the next RESPTALKS webinars featuring Prof. Gevaert and Prof. Toppila-Salmi. They will be shedding light on the underlying inflammation in patients with severe and uncontrolled CRSwNP and how biologics can lead to clinically relevant improvements for these patients.
Speakers
Professor Philippe Gevaert
Philippe Gevaert, MD, Ph.D., is full professor in Rhinology and Allergy at the Department of Otorhinolaryngology and Chairman medical education at the Ghent University, Belgium. Further, he is the scientific coordinator of the Allergy Network of the Ghent University Hospital. Since 1998 he is active in the Upper Airway Research Laboratory at the University of Ghent. He is the past Chairman of the ENT section of the EAACI. Currently, his research is focused on local IgE, allergen specific immunotherapy and biologicals in allergic rhinitis and nasal polyps. He has conducted several academic and industry sponsored clinical trials with novel treatments in nasal polyps and allergic rhinitis. He has published over 200 peer-reviewed papers.
Professor Sanna Toppila-Salmi
Sanna Toppila-Salmi, MD, PhD, Adj. Prof. is a Senior Consultant Otorhinolaryngologist, Department Chief Physician and Director of Helsinki Airway Research Group at the Skin and Allergy Hospital of the Helsinki University Hospital & University of Helinski and Professor at the University of Eastern Finland. Her research group combines epidemiology, genomics, metabolomics and sequence analysis to identify the pathobiology of NERD, type 2 inflammation, CRSwNP, asthma and allergic diseases. Her lab works with human cohorts to identify risk factors, mechanisms, and potential therapies for these disorders using machinge learning data science, sequencing omics approaches and clinical trials.
This webinar is intended for healthcare professionals and is organized by Sanofi North Europe. The event will be reported to ENLI prior to the event.
Dette arrangementet arrangeres i samsvar med avtaler om samhandling som Legemiddelindustri-foreningen har inngått med Den norske legeforening, Norges Farmaceutiske Forening, Norsk Sykepleierforbund og De regionale helseforetakene. For mer informasjon se https://www.lmi.no/lmi/fagomrader/lover-og-regler/samarbeidsavtaler/. Sanofi behandler personopplysninger i henhold til GDPR.